Long-term exposure to fine particulate matter and fasting blood glucose and diabetes in 20 million chinese women of reproductive age
Shen Y, Jiang L, Xie X, et al.
Diabetes Care. Pub. online 22 May 2024.
Leggi
Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials
Leiter LA, Raal FJ, Schwartz GG, et al.
Diabetes Obes Metab. Pub. online 17 May 2024.
Leggi
Tirzepatide 5, 10 and 15 mg versus injectable semaglutide 0.5 mg for the treatment of type 2 diabetes: An adjusted indirect treatment comparison
Osumili B, Fan L, Paik JS, et al.
Diabetes Res Clin Pract. Pub. online 20 May 2024.
Leggi
Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study
Yuan S, Leffler D, Lebwohl B, et al.
Diabetologia. Pub. online 21 May 2024.
Leggi
EMA: Medical devices: new guidance for industry and notified bodies. Question-and-answer document clarifies regulatory requirements for devices used in combination with medicines
21/05/2024
Leggi
FDA Safety Communication – Do not use smartwatches or smart rings to measure blood glucose levels
21/02/2024
Leggi
Hyperlipidaemia in diabetes: are there particular considerations for next generation therapies?
Béliard S, Mourre F, Valéro R
Diabetologia. Pub. online 20 Feb 2024.
Leggi
Non-pharmacological interventions to improve cardiovascular risk factors in people with diabetic foot disease: A systematic review and meta-analysis
Highton P, Almaqhawi A, Oroko M, et al.
Diabetes Research and Clinical Practice. Pub. online 24 Feb 2024.
Leggi
Effect of low dose semaglutide in people with type 1 diabetes and excess weight
Grassi BA, Onetto MT, Sánchez C, Tapia N, Mena F
Diabetes Research and Clinical Practice. Pub. online 24 Feb 2024.
Leggi
Randomized trial of assisted hybrid closed-loop therapy versus sensor-augmented pump therapy in pregnancy
Polsky S, Buschur E, Dungan K, et al.
Diabetes Technol Ther. Pub. online 22 Feb 2024.
Leggi